Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats
about
Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacyThe pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitisPalmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice.Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Mustard vesicants alter expression of the endocannabinoid system in mouse skin.Co-micronized Palmitoylethanolamide/Polydatin Treatment Causes Endometriotic Lesion Regression in a Rodent Model of Surgically Induced Endometriosis.Mast cells: an expanding pathophysiological role from allergy to other disorders.Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.Mast cells, glia and neuroinflammation: partners in crime?Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.Downstream effects of endocannabinoid on blood cells: implications for health and disease.Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patientsDegenerative Joint Diseases and Neuroinflammation.Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.Palmitoylethanolamide Reverses Paclitaxel-Induced Allodynia in Mice.Mast cell-neural interactions contribute to pain and itch.Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect.A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A Review.Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine With Aura: A Pilot Study
P2860
Q28066248-A4FFF739-969E-4C18-979B-6DE44D592CF2Q31122398-FE023B87-D586-4066-A3BC-762855BAEB17Q34488693-5DC7BE5F-0C0F-4F55-A88E-0F907D50BC56Q34640959-B8516993-1AA5-4B5F-9C2C-548A93B4582AQ34645584-FC08308E-2C43-4347-B40A-F62010D68033Q35939665-96DB3785-6365-4B2B-97B9-F08C4FD4B3B7Q36348374-AB7B61B5-B2B9-4112-B53E-293DA232443FQ37099962-96E13EF1-3F5E-4963-B00E-A9BDE4284920Q37338638-A17434BC-6716-4BFC-AA44-98C93C376E84Q38007884-5BAB00DB-B1A2-4605-993E-AB18A7214C86Q38118187-FC24DF88-8D70-4F65-904C-CBB34501F4E3Q38137173-5102DD99-7B10-4E40-92E4-C11C86499ECAQ38157791-12EE2A6D-1CB0-483E-9A51-D938088B2C41Q38468985-1680CC5D-9A3C-4541-81EF-50C42BBC8729Q38908402-24896096-A329-455F-BCD3-AA50550B09B4Q39063573-0B90C3C8-1748-44D7-BA54-967DF0200603Q41953638-6F245DBA-AD6D-4806-857C-FF4D532181C7Q42713290-F14E7D6C-8EE9-44A7-94F8-ECE1D847F112Q50068940-D69ECA19-59B3-4902-8DDC-9E3A221A23B1Q51510329-1713F4F5-1F21-4A7D-9230-016E4FDDE961Q52608759-4C3A73CE-CB9F-4BF7-9579-D033E1DD2D10Q55236616-F8E7BC6B-4EFC-4D15-9218-4D45F433C3E2Q58769031-FE074BAC-84AB-4608-B867-8C1CF097F769
P2860
Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@ast
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@en
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@en-gb
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@nl
type
label
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@ast
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@en
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@en-gb
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@nl
prefLabel
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@ast
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@en
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@en-gb
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Palmitoylethanolamide reduces ...... f mast cell activation in rats
@en
P2093
Daniele De Filippis
Enza Palazzo
Maria Pia Cinelli
Teresa Iuvone
P2860
P2888
P3181
P356
10.1186/1744-8069-7-3
P407
P577
2011-01-01T00:00:00Z
P5875
P6179
1051434537